Keyword: Congress

Congress' massive coronavirus stimulus likely pushes back any drug pricing action until after the election.

Despite COVID-19, lawmakers are pushing forward with their drug pricing efforts, and President Donald Trump has called for a bipartisan solution.

Congress passed an $8.3 billion spending bill to contain the U.S. coronavirus outbreak, but the process was not without argument about drug prices.

Martha McSally is locked in a tough fight for reelection, and now she's rolling out a pricing proposal that breaks with her party in some areas.

Complacent about drug-pricing action in Congress? Despite the chaos of impeachment and elections, lawmakers are still taking drug pricing seriously.

The jury's out on how Washington will move on drug pricing this year, but one analyst believes 2020 will bring "minimal action."

With U.S. elections looming and drug pricing a hot-button issue for voters, will lawmakers take action, or will gridlock continue in 2020?

Drug pricing remains a prominent topic heading into 2020, and developments last week show pharma will likely be on the defensive during the election.

Stephen Hahn, an oncologist who served as the chief medical officer for the MD Anderson Cancer Center, has secured Senate confirmation as FDA head.

This week could bring a drug pricing showdown in the House as Dems plan to vote on Pelosi’s bill and Republicans aim to unveil their own bill.